S5043
Referred to committee
A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.
- Federal
- Senate
- Introduced Jul 21, 2026
- Session 119
Bill Text
The full text for this bill hasn't been synced yet.
Read it on Congress.govLegislative Timeline
2 actions-
Introduced in Senate
-
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.